Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

12.1K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

76.9K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Optimizing phage therapy with antidefense proteins acquired from the environment.

Frontiers in microbiology·2026
Same author

Intermolecular C─H···M (M = Fe and V) Interactions in Metalloporphyrins: A Combined Experimental and Computational Perspective.

Chemphyschem : a European journal of chemical physics and physical chemistry·2026
Same author

Zinc-Porphyrin Terephthalate-Based Metal-Organic Framework: Structural Insights and Functional Antibacterial Properties.

Chembiochem : a European journal of chemical biology·2026
Same author

Diversity of DNA viruses in the atmosphere of sub-Antarctic South Georgia.

Frontiers in microbiology·2026
Same author

Incorporation of Functional Proteins on Cellular Surfaces via Artificial Cell-Derived Vesicles (ACDVs) for Plasma Membrane Reprogramming.

Journal of the American Chemical Society·2026
Same author

Polymeric Lysosome-Targeting Chimeras (PolyTACs): Extracellular Targeted Protein Degradation without Co-Opting Lysosome-Targeting Receptors.

Journal of the American Chemical Society·2026

相关实验视频

Updated: May 23, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K

只有双作用的PROTAC

Ranit Dutta1,2, Anirudh Devarajan1,2, Amelia Talluri1

  • 1Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.

Journal of the American Chemical Society
|March 10, 2025
PubMed
概括

这项研究介绍了一种新的药物技术 - - 单双作用PROTACs (DAO-PROTACs). 这些PROTAC需要低氧和cathepsin- L来激活,从而减少副作用并提高安全性.

更多相关视频

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.4K
A Protocol for Real-time 3D Single Particle Tracking
10:16

A Protocol for Real-time 3D Single Particle Tracking

Published on: January 3, 2018

14.8K

相关实验视频

Last Updated: May 23, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.4K
A Protocol for Real-time 3D Single Particle Tracking
10:16

A Protocol for Real-time 3D Single Particle Tracking

Published on: January 3, 2018

14.8K

科学领域:

  • 药物发现和开发
  • 分子生物学
  • 生物化学

背景情况:

  • 针对蛋白质分解的仿真体 (PROTACs) 是一种强效的伪催化剂.
  • 在目标上,在场外的PROTAC可以导致不良后果.
  • 有针对性的蛋白质降解提供了一个有前途的治疗策略.

研究的目的:

  • 开发一个可通用的AND逻辑门的PROTAC系统,用于向蛋白质降解.
  • 设计由双重疾病相关的内源刺激激活的PROTAC分子.
  • 为了减轻与基于PROTAC的治疗相关的细胞毒性.

主要方法:

  • 单双作用的PROTAC (DAO-PROTAC) 分子的设计和合成
  • 开发一种需要低氧和甲素-L的双刺激激活机制.
  • 与自由PROTAC和单刺激PROTAC相比,DAO- PROTAC活性和细胞毒性的评估

主要成果:

  • DAO- PROTACs处于休眠状态,直到被低氧和甲素- L的同时存在激活.
  • DAO- PROTACs的激活导致所需蛋白质 (POI) 的降解.
  • 与传统的PROTAC相比,DAO- PROTAC的细胞毒性显著降低.

结论:

  • DAO-PROTAC代表了一种用于精确蛋白质降解的新AND逻辑门式方法.
  • 双刺激激活提高了基于PROTAC的治疗方法的安全性.
  • 这项技术有可能为更安全,更有效的向蛋白质降解疗法提供帮助.